News for Bristol-Myers Squibb Company (BMY)

Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb BMY, and it's something market players shouldn't ignore. Our tracking of pu...

Originally published by The Robert A. Winn Excellence In Clinical Trials Award Program NORTHAMPTON, MA / ACCESS Newswire / July 14, 2025 / The Robert A. Winn Cl

SOMERSET, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. ( CMPO), a leader in metal payment cards, security, and authentication solutions, today an

Bristol-Myers Squibb is set to announce its second-quarter results by the end of July, and analysts expect a notable drop in earnings.

On June 17, the company declared a quarterly dividend of $0.62 per share, which was consistent with its previous dividend.

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best Passive Income Stocks to Buy Now. On June 17, the company declared a quarterly dividend of $0.62 per share, which was consistent with its previous dividend. Overall, it has raised its payouts for 16 consecutive years and has delivered uninterrupted payouts for 93 years in […]

Bristol Myers Squibb is undervalued despite challenges. Learn how BMY stock's strong pipeline, cash flow, and growth strategies offset patent expiries.

Bristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. Bridgewater Associates holds over $142 million worth of shares of BMY, which represents 0.66% of its portfolio. On June 25, 2025, Bristol-Myers Squibb Company (NYSE:BMY) announced a new update regarding its plans for breast cancer treatments. […]

Business Insider's July 30 virtual event features executives talking about procurement innovation strategies. The panel features experts from Bristol-Myers Squibb and Amazon Business.

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

The adoption of artificial intelligence (AI) software is increasing at an incredible pace because of the productivity and efficiency gains this technology is capable of delivering, and the good part is that this niche is likely to sustain a healthy growth rate over the long run. According to ABI Research, the AI software market is expected to clock a compound annual growth rate (CAGR) of 25% through 2030, generating $467 billion in annual revenue at the end of the decade.

Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every year since 2009. Loss of patent-protected exclusivity for several blockbuster drugs is expected to reduce Pfizer's sales a great deal over the next few years.

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 HYPERION study evaluating WI

**media[660849,660850]**

[url="]Bristol Myers Squibb[/url] (NYSE: BMY) today announced the first disclosure of the primary analysis results of the marginal zone lymphoma (MZL) cohort o

Bristol-Myers Squibb Company (NYSE:BMY) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 10:00 AM ETCompany ParticipantsAdam Lenkowsky -...

Philochem & RayzeBio unite for prostate cancer diagnostic advancement. Read more here.

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.